Long-term citrate treatment in high-risk kidney stone formers is not associated with metabolic adverse effects

Alexander Ritter, Lea Bührer, Daniel G Fuster, Nasser A Dhayat, Olivier Bonny, Gregoire Wuerzner, Thomas Ernandez, Florian Buchkremer, Stephan Segerer, Laura Keller, Maximilian Sabev, Daniel S Engeler, Beat Roth, Pietro M Ferraro, Ulrike Held, Nilufar Mohebbi, Carsten A Wagner, Harald Seeger

Open source

DOI
10.1093/ckj/sfag058
Published
2026-03-09
Container
Clinical Kidney Journal
Publisher
Oxford University Press (OUP)
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1093/ckj/sfag058,
  title = {Long-term citrate treatment in high-risk kidney stone formers is not associated with metabolic adverse effects},
  author = {Alexander Ritter and Lea Bührer and Daniel G Fuster and Nasser A Dhayat and Olivier Bonny and Gregoire Wuerzner and Thomas Ernandez and Florian Buchkremer and Stephan Segerer and Laura Keller and Maximilian Sabev and Daniel S Engeler and Beat Roth and Pietro M Ferraro and Ulrike Held and Nilufar Mohebbi and Carsten A Wagner and Harald Seeger},
  year = {2026},
  journal = {Clinical Kidney Journal},
  doi = {10.1093/ckj/sfag058},
  url = {https://doi.org/10.1093/ckj/sfag058}
}

RIS

TY  - JOUR
TI  - Long-term citrate treatment in high-risk kidney stone formers is not associated with metabolic adverse effects
AU  - Alexander Ritter
AU  - Lea Bührer
AU  - Daniel G Fuster
AU  - Nasser A Dhayat
AU  - Olivier Bonny
AU  - Gregoire Wuerzner
AU  - Thomas Ernandez
AU  - Florian Buchkremer
AU  - Stephan Segerer
AU  - Laura Keller
AU  - Maximilian Sabev
AU  - Daniel S Engeler
AU  - Beat Roth
AU  - Pietro M Ferraro
AU  - Ulrike Held
AU  - Nilufar Mohebbi
AU  - Carsten A Wagner
AU  - Harald Seeger
PY  - 2026
JO  - Clinical Kidney Journal
DO  - 10.1093/ckj/sfag058
UR  - https://doi.org/10.1093/ckj/sfag058
ER  - 

APA

Ritter, A., Bührer, L., Fuster, D. G., Dhayat, N. A., Bonny, O., Wuerzner, G., Ernandez, T., Buchkremer, F., Segerer, S., Keller, L., Sabev, M., Engeler, D. S., Roth, B., Ferraro, P. M., Held, U., Mohebbi, N., Wagner, C. A., & Seeger, H. (2026). Long-term citrate treatment in high-risk kidney stone formers is not associated with metabolic adverse effects. Clinical Kidney Journal. https://doi.org/10.1093/ckj/sfag058

Source records